marks published for opposition - U.S. Patent and Trademark Office

TM 1442 OFFICIAL GAZETTE JULY 17, 2012
CLASS 10—(Continued).
4,175,843. CLRS TECHNOLOGY CORPORATION, COSTA
MESA, CA. SN 77-410,281. PUB. 3-6-2012, FILED 2-29-2008.
THE MARK CONSISTS OF STANDARD CHARACTERS
WITHOUT CLAIM TO ANY PARTICULAR FONT, STYLE,
SIZE, OR COLOR.
OWNER OF U.S. REG. NO. 3,846,433.
THE FOREIGN WORDING IN THE MARK TRANSLATES
INTO ENGLISH AS "CLEAR".
FOR MEDICAL DEVICES, NAMELY, PHOTOTHERA-
PEUTIC APPARATUS FOR MEDICAL PURPOSES,
NAMELY, DEVICES FOR USE IN THE TREATMENT
OF DERMATOLOGICAL CONDITIONS INCLUDING
ACNE (U.S. CLS. 26, 39 AND 44).
FIRST USE 9-26-2008; IN COMMERCE 9-26-2008.
4,175,925. FITNESS ARCH, INC., MOUNTLAKE TERRACE,
WA. SN 77-718,698. PUB. 9-1-2009, FILED 4-21-2009.
THE MARK CONSISTS OF STANDARD CHARACTERS
WITHOUT CLAIM TO ANY PARTICULAR FONT, STYLE,
SIZE, OR COLOR.
NO CLAIM IS MADE TO THE EXCLUSIVE RIGHT TO
USE "FITNESS", APART FROM THE MARK AS SHOWN.
FOR EXERCISE MACHINES FOR THERAPEUTIC
PURPOSES (U.S. CLS. 26, 39 AND 44).
FIRST USE 11-20-2011; IN COMMERCE 11-20-2011.
4,175,979. NIKKEN, INC., IRVINE, CA. SN 77-832,019. PUB. 7-
20-2010, FILED 9-22-2009.
THE MARK CONSISTS OF STANDARD CHARACTERS
WITHOUT CLAIM TO ANY PARTICULAR FONT, STYLE,
SIZE, OR COLOR.
FOR PERMANENT MAGNETS SOLD AS A COMPO-
NENT OF FINISHED APPARATUS FOR MAGNET
THERAPY TO BE SOLD THROUGH A DIRECT SALES,
MULTILEVEL MARKETING, OR PERSON-TO-PERSON
SALES FORMAT (U.S. CLS. 26, 39 AND 44).
FIRST USE 10-23-2009; IN COMMERCE 10-23-2009.
CLASS 10—(Continued).
4,175,981. ETEX CORPORATION, CAMBRIDGE, MA. SN 77-
834,591. PUB. 3-22-2011, FILED 9-24-2009.
THE MARK CONSISTS OF THE GREEK LETTER GAM-
MA TO THE LEFT OF THE WORDS "GAMMA-BSM".
FOR ARTIFICIAL BONE SUBSTITUTION MATERIAL
(U.S.CLS.26,39AND44).
FIRST USE 5-27-2009; IN COMMERCE 6-30-2009.
4,175,989. RAINTREE ESSIX INC., WILMINGTON, DE. SN
77-845,791. PUB. 3-16-2010, FILED 10-9-2009.
THE MARK CONSISTS OF STANDARD CHARACTERS
WITHOUT CLAIM TO ANY PARTICULAR FONT, STYLE,
SIZE, OR COLOR.
FOR DENTAL INSTRUMENTS FOR USE IN REDU-
CING OR CONTOURING TOOTH COATING (U.S. CLS.
26, 39 AND 44).
FIRST USE 3-19-2012; IN COMMERCE 3-19-2012.
4,176,022. INTERSECT ENT, INC., PALO ALTO, CA. SN 77-
882,268. PUB. 11-16-2010, FILED 11-30-2009.
THE MARK CONSISTS OF STANDARD CHARACTERS
WITHOUT CLAIM TO ANY PARTICULAR FONT, STYLE,
SIZE, OR COLOR.
FOR MEDICAL DEVICES CONSISTING OF ARTIFI-
CIAL MATERIALS FOR THE TREATMENT OF EAR,
NOSE, THROAT, SINUS AND RESPIRATORY-RELATED
CONDITIONS AND SYMPTOMS, NAMELY, IMPLANTS
COMPRISED OF DRUG-ELUTING STENTS; DRUG DE-
LIVERY SYSTEMS; SURGICAL DEVICES AND INSTRU-
MENTS FOR THE TREATMENT OF EAR, NOSE,
THROAT, SINUS AND RESPIRATORY-RELATED CON-
DITIONS AND SYMPTOMS (U.S. CLS. 26, 39 AND 44).
FIRST USE 8-31-2010; IN COMMERCE 8-30-2011.